Sbir phase I: AK-423: a broad-spectrum antiviral and immunomodulatory agent (COVID-19)
Ended Project Grant Awarded Last action
- Award ID
- 2032097
- Recipient
-
Akanocure Pharmaceuticals Inc. UEI QMU8ZFLN2A34
- Awarding agency
-
National Science Foundation
- Obligated
- $256,000
Award facts
- Assistance listing
- 47.084 NSF Technology, Innovation, and Partnerships
- Completion date
- Originally
- Place of performance
- West Lafayette, IN, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $256,000 |
Quick answers
Who received award 2032097?
2032097 was awarded to Akanocure Pharmaceuticals Inc. by National Science Foundation on January 1, 2021.
How much is award 2032097 worth?
$256,000 has been obligated on 2032097.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award